Sarepta’s Elevidys Limited To Ambulatory DMD Patients

Study In Non-Ambulatory Patients Planned

 
• By Mandy Jackson
  
Elevidys is contraindicated in patients with DMD exon 8 and/or 9 deletions (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Scrip

More from Rare Diseases